Cross-talk among structural domains of human DBP upon binding 25-hydroxyvitamin D

Biochemical and Biophysical Research Communications

Volumn 365, Issue 4, 2008, Pages 746-750

  Ray, Arjun ^a   Swamy, Narasimha ^a   Ray, Rahul ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

2 p Toluidinyl 6 sulfonate (TNS); 25 Hydroxyvitamin D3 (25 OH D3); Conformational change; Cross talk among domains; Reporter molecule; Structural domains of vitamin D binding protein (DBP)

Indexed keywords

2 4 TOLUIDINYL 6 SULFONIC ACID; 25 HYDROXYVITAMIN D; CALCIFEDIOL; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG; VITAMIN D BINDING PROTEIN;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; FLUORESCENCE; HUMAN; HYDROPHOBICITY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN STRUCTURE;

BINDING SITES; HUMANS; PROTEIN BINDING; VITAMIN D; VITAMIN D-BINDING PROTEIN;

EID: 36849041688     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.11.033     Document Type: Article

References (34)

1. Haddad J.G. Plasma vitamin D-binding protein (Gc-globulin): multiple tasks. J. Steroid Biochem. Mol. Biol. 53 (1995) 579-582
2. Ray R. Molecular recognition in vitamin D-binding protein. Proc. Soc. Exp. Biol. Med. 212 (1996) 305-312
3. Haddad J.G., and Cooke N.E. Vitamin D-binding protein (Gc-globulin). Endocr. Rev. 10 (1989) 294-307
4. Van Baelen H., Bouillon R., and DeMoor P. Vitamin D-binding protein (Gc globulin) binds actin. J. Biol. Chem. 255 (1980) 2270-2272
5. Haddad J.G. Human serum binding protein for vitamin D and its metabolites (DBP): evidence that actin is the DBP binding component in human skeletal muscle. Arch. Biochem. Biophys. 213 (1982) 538-544
6. Goldschmidtt-Clermont P.J., van Baelen H., Bouillon R., Shook T.E., Williams M.H., Nel A.E., and Galbraith R.M. Role of group-specific component (vitamin D binding protein) in clearance of actin from the circulation in rabbit. J. Clin. Invest. 81 (1988) 1519-1527
7. Lee W.M., and Galbraith R.M. The extracellular actin-scavenger system and actin toxicity. N. Engl. J. Med. 326 (1992) 1335-1341
8. Lind S.E., Smith D.B., Janmey P.A., and Stossel T.P. Role of plasma gelsolin and vitamin D binding protein in clearing actin from circulation. J. Clin. Invest. 78 (1986) 736-742
9. Shah A.B., DiMartino S.J., Trujillo G., and Kew R.R. Selective inhibition of the C5a chemotactic cofactor function of the vitamin D binding protein by 1,25(OH)2vitamin D3. Mol. Immunol. 43 (2006) 1109-1115
10. Zhang J., and Kew R.R. Identification of a region in the vitamin D binding protein that mediates its C5a chemotactic function. J. Biol. Chem. 279 (2004) 53282-53287
11. Ena J.M., Esteban C., Perez M.D., Uriel J., and Calvo M. Fatty acids bound to vitamin D-binding protein (DBP) from human and bovine sera. Biochem. Int. 19 (1989) 1-7
12. Bouillon R., Xiang D.Z., Convents R., and Van Baelen H. Polyunsaturated fatty acids decrease the apparent affinity of vitamin D metabolites for human vitamin D-binding protein. J. Steroid Biochem. Mol. Biol. 42 (1992) 855-861
13. 3 binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytes. Proc. Natl. Acad. Sci. 88 (1991) 8539-8543
14. 3 binding protein (group-specific component) to a macrophage activating factor by the stepwise action of beta-galactosidase of B cells and sialidase of T cells. J. Immunol. 151 (1993) 2794-2802
15. Yamamoto N., Lindsay D.D., Naraparaju V.R., Ireland R.A., and Popoff S.N. A defect in the inflammation-primed macrophage-activation cascade in osteopetrotic rats. J. Immunol. 152 (1994) 5100-5107
16. Schneider G.B., Benis K.A., Flay N.W., Ireland R.A., and Popoff S.N. Effects of vitamin D binding protein-macrophage activating factor (DBP-MAF) infusion on bone resorption in two osteopetrotic mutations. Bone 16 (1995) 657-662
17. 3 does not influence this activity. J. Cell Biochem. 81 (2001) 535-546
18. Koga Y., Naraparaju V.R., and Yamamoto N. Antitumor effect of vitamin D-binding protein-derived macrophage activating factor on Ehrlich ascites tumor-bearing mice. Proc. Soc. Exp. Biol. Med. 220 (1999) 20-26
19. Kisker O., Onizuka S., Becker C.M., Fannon M., Flynn E., D'Amato R., Zetter B., Folkman J., Ray R., Swamy N., and Pirie-Shepherd S. Vitamin D binding protein macrophage activating factor (DBP-maf) inhibits angiogenesis and tumor growth in mice. Neoplasia 5 (2003) 32-40
20. Cooke N.E., and David E.V. Serum vitamin D-binding protein is a third member of the albumin and alpha-fetoprotein gene family. J. Clin. Invest. 76 (1985) 2420-2424
21. Yang F., Brune J.I., Naylor S.L., Cupples R.L., Naberhaus K.H., and Bowman B.H. Human group specific component (Gc) is a member of the albumin family. Proc. Natl. Acad. Sci. USA 82 (1985) 7994-7998
22. Lichenstein H.S., Lyons D.E., Wurfel M.M., Johnson D.A., McGinley M.D., Ledili J.C., Trollinger D.b., Mayer J.P., Wright S.D., and Kukowski M.M. Afamin is a new member of the albumin, alpha fetoprotein and vitamin d-binding protein gene family. J. Biol. Chem. 269 (1994) 18149-18154
23. Haddad J.G., Hu Y.Z., Kowalski M.A., Laramore C., Ray K., Robzyk P., and Cooke N.E. Identification of the sterol- and actin-binding domains of plasma vitamin D binding protein (Gc-globulin). Biochemistry 31 (1992) 7174-7181
24. 3-binding site. Biochemistry 30 (1991) 7638-7642
25. Swamy N., Head J.F., Weitz D., and Ray R. Biochemical and preliminary crystallographic characterization of the vitamin d sterol- and actin-binding by human vitamin d-binding protein. Arch. Biochem. Biophys. 402 (2002) 14-23
26. Head J.F., Swamy N., and Ray R. Crystal structure of the complex between actin and human vitamin D-binding protein at 2.5A resolution. Biochemistry 41 (2002) 9015-9020
27. Verboven C., Bogaerts I., Waelkens E., Rabjins A., Van Baelen H., Bouillon R., and De Ranter C. Actin-DBP: the perfect structural fit?. Acta Crystallogr. D Biol. Crystallogr. 59 (2003) 263-273
28. Schoentgen F., Metz-Boutigue M., Jolles J., Constans J., and Jolles P. Complete amino acid sequence of human vitamin D-binding protein (group specific component): evidence of a three fold internal homology as in serum albumin and alpha-feto protein. Biochem. Biophys. Acta 871 (1986) 189-198
29. Swamy N., Roy A., Chang R., Brisson M., and Ray R. Affinity purification of human plasma vitamin D-binding protein. Protein Expr. Purif. 6 (1995) 185-188
30. Swamy N., Ghosh S., and Ray R. Bacterial expression of human vitamin D-binding protein (Gc2) in functional form. Protein Expr. Purif. 10 (1997) 115-122
31. 3 to human serum vitamin D-binding protein. J. Biol. Chem. 270 (1995) 2636-2639
32. McClure W.O., and Edelman G.M. Fluorescent probes for conformational states of proteins. I. Mechanism of fluorescence of 2-p-toluidinylnapthalene-6-sulphonate, a hydrophobic probe. Biochemistry 5 (1966) 1908-1918
33. Goldschmidt-clermont P.J., Williams M.H., and Galbraith R.M. Altered conformation of Gc (vitamin D binding protein) upon complexing with cellular actin. Biochem. Biophys. Res. Commun. 146 (1987) 611-617
34. Emes A.V., Latner A.L., Martin J.A., and Mulligan F.A. Studies on the binding of haemoglobin by haptoglobin using electrofocusing and gradient electrophoresis. Biochem. Biophys. Acta 420 (1976) 57-68